Hana Bio's Zofran rival enters new trial
home > blogdigger
Hana Biosciences has announced a new clinical trial to compare its oral spray formulation of ondansetron to the approved oral dosage of GlaxoSmithKline's Zofran, the world's best-selling anti-emetic agent.
- link to Hana Bio's Zofran rival enters new trial -
Last update: 05/26/2005